Table 3.
Health, Budgetary, and Economic Outcomes With Sodium Reduction Policy by Age and Sex Subgroups
| Difference attributable to sodium reduction policy | ||||
|---|---|---|---|---|
| Outcomes | Ages 35–64 years | Ages ≥65 years | Men | Women |
| At 10 years | ||||
| Individuals SBP ≥140 mmHg (millions) | −4.0 | −2.9 | −3.9 | −3.0 |
| Individuals with SBP 120–139 mmHg (millions) | −6.8 | −1.3 | −4.7 | −3.4 |
| Over 10 years | ||||
| Person-years above goal (millions) | −26 | −16 | −24 | −18 |
| Incident MI (thousands) | −92 | −127 | −156 | −63 |
| Incident strokea (thousands) | −65 | −220 | −147 | −137 |
| Incident CVD events (thousands) | −265 | −630 | −530 | −365 |
| Incident CVD death (thousands) | −39 | −214 | −157 | −95 |
| CVD costs, total (billions $) | −12 | −25 | −22 | −15 |
| Total productivity (billions $) | 5 | 13 | 12 | 6 |
Note: The Incident CVD events rows combine incident MI, incident stroke, incident hospitalization for congestive heart failure, onset of angina pectoris, and onset of intermittent claudication. All costs are in undiscounted 2017 U.S. dollars.
Incident stroke includes incident ischemic and hemorrhagic stroke.
CVD, cardiovascular disease; MI, myocardial infarction; SBP, systolic blood pressure.